23.82

0.97% +0.23

Doximity Inc (DOCS)

Overview News Price History Option Chain Why DOCS Down? Discussions Forecast

Doximity Inc stock is currently priced at $23.82, with a 24-hour trading volume of 830.76K. It has seen a +0.97% increased in the last 24 hours and a -11.75% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $23.58 pivot point. If it approaches the $23.89 resistance level, significant changes may occur.

Previous Close:

$23.59

Open:

$23.66

24h Volume:

830.76K

Market Cap:

$4.44B

Revenue:

$468.33M

Net Income/Loss:

$137.63M

P/E Ratio:

43.31

EPS:

0.55

Net Cash Flow:

$161.60M

1W Performance:

-3.29%

1M Performance:

-11.75%

6M Performance:

+13.11%

1Y Performance:

-33.09%

1D Range:

$23.54

$24.10

52W Range:

$19.71

$36.92

Doximity Inc Stock (DOCS) Company Profile

Name

Doximity Inc

Sector

Healthcare (1191)

Industry

Health Information Services (62)

Phone

650 549 4330

Address

500, 3rd Street, Suite 510, San Francisco

Employee

713

Twitter

Next Earnings Date

2024-05-16

Latest SEC Filings

DOCS's Discussions on Twitter

Doximity Inc Stock (DOCS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-03-24	Initiated	Barclays	Equal Weight
Jan-02-24	Upgrade	BofA Securities	Underperform → Neutral
Aug-09-23	Downgrade	Guggenheim	Buy → Neutral
Aug-09-23	Downgrade	Needham	Buy → Hold
Aug-03-23	Downgrade	Piper Sandler	Overweight → Neutral
May-01-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Oct-31-22	Initiated	Wells Fargo	Overweight
Oct-24-22	Initiated	Evercore ISI	In-line
Oct-13-22	Initiated	BTIG Research	Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-05-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-28-22	Initiated	Berenberg	Buy
May-18-22	Reiterated	BofA Securities	Neutral
May-18-22	Reiterated	Goldman	Buy
May-18-22	Reiterated	Guggenheim	Buy
May-18-22	Reiterated	Jefferies	Buy
May-18-22	Reiterated	Morgan Stanley	Equal-Weight
May-18-22	Reiterated	Needham	Buy
Apr-07-22	Initiated	Guggenheim	Buy
Apr-04-22	Initiated	BofA Securities	Neutral
Feb-11-22	Initiated	Goldman	Buy
Dec-14-21	Downgrade	JP Morgan	Neutral → Underweight
Dec-02-21	Initiated	Jefferies	Buy
Nov-17-21	Initiated	Robert W. Baird	Outperform
Nov-10-21	Reiterated	Canaccord Genuity	Buy
Nov-10-21	Reiterated	Goldman	Neutral
Nov-10-21	Reiterated	Morgan Stanley	Equal-Weight
Nov-10-21	Reiterated	Needham	Buy
Nov-10-21	Reiterated	Piper Sandler	Overweight
Aug-26-21	Downgrade	JP Morgan	Overweight → Neutral
Jul-19-21	Initiated	Canaccord Genuity	Buy
Jul-19-21	Initiated	Goldman	Neutral
Jul-19-21	Initiated	JP Morgan	Overweight
Jul-19-21	Initiated	Morgan Stanley	Equal-Weight
Jul-19-21	Initiated	Piper Sandler	Overweight
Jul-19-21	Initiated	Raymond James	Outperform
Jul-19-21	Initiated	SVB Leerink	Outperform
Jul-19-21	Initiated	William Blair	Outperform

View All

Doximity Inc Stock (DOCS) Latest News

Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?

Zacks Investment Research

Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?

Zacks Investment Research

SGRY vs. DOCS: Which Stock Should Value Investors Buy Now?

Zacks Investment Research

Doximity Inc Stock (DOCS) Financials Data

Doximity Inc (DOCS) Revenue 2024

DOCS reported a revenue (TTM) of $468.33 million for the quarter ending December 31, 2023, a +16.58% rise year-over-year.

Doximity Inc (DOCS) Net Income 2024

DOCS net income (TTM) was $137.63 million for the quarter ending December 31, 2023, a +15.78% increase year-over-year.

Doximity Inc (DOCS) Cash Flow 2024

DOCS recorded a free cash flow (TTM) of $161.60 million for the quarter ending December 31, 2023, a -6.41% decrease year-over-year.

Doximity Inc (DOCS) Earnings per Share 2024

DOCS earnings per share (TTM) was $0.66 for the quarter ending December 31, 2023, a +20.00% growth year-over-year.

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.